Not surprisingly, Ins, IGF-1, IGF-2 and their receptors (IR, IGF-1R and IGF-2R) and binding proteins (IGFBPs) constitute the Ins/IGF system (IIGFs), a critical signaling network well-dissected for its role in malignant progression also in BC [10, 11]. This evidence concerns the gene IGF2 and breast cancer.